IE 11 is a very old browser and is not supported on this site.

31. Group companies

Group companies Products & Care

 

 

 

 

 

2025

2024

Group companies

Registered office

Method of consolidation

Currency

Share capital in thousand

Equity interest

Equity interest

Products & Care

 

 

 

 

 

 

Amavita Health Care Ltd.

CH-Niederbipp

full

CHF

100

100%

100%

Bahnhof Apotheke Langnau AG

CH-Langnau im Emmental

full

CHF

100

100%

100%

Bahnhof Apotheken Thun AG

CH-Thun

full

CHF

200

50%

50%

Bichsel AG 1)

CH-Interlaken

full

CHF

100

100%

100%

Coop Vitality AG

CH-Bern

at equity

CHF

5,000

49%

49%

Coop Vitality Health Care GmbH 1)

CH-Niederbipp

at equity

CHF

20

49%

49%

Coop Vitality Management AG

CH-Bern

at equity

CHF

100

49%

49%

curarex swiss AG 1) 2)

CH-Zuchwil

-

-

-

-

49%

Diagnostics Group LLC

CH-Goldach

full

CHF

1,000

100%

-

Dr. A.&L. Schmidgall GmbH & Co KG 1)

AT-Vienna

full

EUR

145

100%

100%

Emeda Ltd.

CH-Wangen-Brüttisellen

at equity

CHF

200

50%

50%

FARMACIA CHIASSESE FARMADOMO SA 1)

CH-Chiasso

at equity

CHF

100

33%

33%

Farmadomo Home Care Provider SA

CH-Bellinzona

at equity

CHF

100

33%

33%

GaleniCare Ltd.

CH-Bern

full

CHF

700

100%

100%

GaleniCare Management Ltd.

CH-Bern

full

CHF

500

100%

100%

G-Pharma AG

CH-Niederbipp

full

CHF

100

100%

100%

Grosse Apotheke Dr. G. Bichsel AG 1)

CH-Interlaken

full

CHF

200

100%

100%

Haemoclot AG 1)

CH-Zürich

full

CHF

100

100%

-

Hedoga AG

CH-Villars-sur-Glâne

full

CHF

100

100%

100%

Laboratorium Dr. G. Bichsel AG 1)

CH-Unterseen

full

CHF

200

100%

100%

Labor Team Holding Ltd. 1)

CH-Goldach

full

CHF

100

100%

-

labor team (liechtenstein) ag 1)

LI-Schaan

full

CHF

50

100%

-

labor team w ag 1)

CH-Goldach

full

CHF

6,210

100%

-

Lifestage Solutions Ltd.

CH-Otelfingen

full

CHF

152

100%

100%

Medifilm Ltd.

CH-Oensingen

full

CHF

1,300

100%

100%

medinform AG

CH-Zürich

full

CHF

100

50%

50%

MediService Ltd.

CH-Zuchwil

at equity

CHF

363

49%

49%

Modern-Path SA 1)

CH-Montreux

full

CHF

100

80%

-

MolecWise AG 1)

CH-Goldach

at equity

CHF

200

40%

-

PADMA Inc.

CH-Wetzikon

full

CHF

152

100%

100%

Padma Aktiengesellschaft für tibetische Heilmittel 1)

CH-Freienbach

full

CHF

100

100%

100%

PADMA EUROPE GmbH 1)

AT-Vienna

full

EUR

35

100%

100%

PADMA Deutschland GmbH 1)

DE-Gräfelfing

full

EUR

25

100%

100%

puravita AG

CH-Speicher

at equity

CHF

189

47.09%

34.34%

Schmidgall GmbH 1)

AT-Vienna

full

EUR

36

100%

100%

Spagyros Ltd.

CH-Worb

full

CHF

860

100%

100%

Sun Store Health Care Ltd.

CH-Niederbipp

full

CHF

100

100%

100%

SWISS PHARMA GmbH

DE-Rülzheim

full

EUR

51

100%

100%

Verfora Ltd.

CH-Villars-sur-Glâne

full

CHF

100

100%

100%

Winconcept Ltd.

CH-Bern

full

CHF

100

100%

100%

Zentral Apotheke Heerbrugg AG

CH-Au

full

CHF

100

100%

100%

1) Not directly held by Galenica Ltd.

2) The company was merged into MediService Ltd.

Group companies Logistics & IT and Group Services

 

 

 

 

 

2025

2024

Group companies

Registered office

Method of consolidation

Currency

Share capital in thousand

Equity interest

Equity interest

Logistics & IT

 

 

 

 

 

 

1L Logistics Ltd.

CH-Burgdorf

full

CHF

100

100%

100%

Alloga Ltd.

CH-Burgdorf

full

CHF

8,332

100%

100%

Aquantic AG

CH-Rheinfelden

full

CHF

100

100%

100%

Dauf SA 1)

CH-Lugano

full

CHF

100

94.54%

94.54%

Galexis Ltd.

CH-Niederbipp

full

CHF

25,000

100%

100%

HCI Solutions Ltd.

CH-Bern

full

CHF

100

100%

100%

Health Supply Ltd.

CH-Villmergen

at equity

CHF

100

40%

40%

Pharma-Info AG 2)

CH-Biel

-

-

-

-

49%

PharmaBlist Ltd. 1)

CH-Widnau

full

CHF

100

100%

100%

Pharmapool Ltd. 1)

CH-Widnau

full

CHF

962

100%

100%

Unione Farmaceutica Distribuzione SA

CH-Lugano

full

CHF

2,000

94.54%

94.54%

Group Services

 

 

 

 

 

 

Galenica Finanz Ltd.

CH-Bern

full

CHF

100

100%

100%

1) Not directly held by Galenica Ltd.

2) The company was sold in the second half of 2025

Galenica uses cookies to optimise the functions of the website and to ensure you enjoy the best possible experience. Use of cookies & disclaimer